RT Journal Article SR Electronic T1 Fat-enlarged Axillary Lymph Nodes are Associated with Node-Positive Breast Cancer in Obese Patients JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.02.17.20246504 DO 10.1101/2021.02.17.20246504 A1 Roberta M. diFlorio-Alexander A1 Qingyuan Song A1 Dennis Dwan A1 Judith A. Austin-Strohbehn A1 Kristen E. Muller A1 William B. Kinlaw A1 Todd A. MacKenzie A1 Margaret R. Karagas A1 Saeed Hassanpour YR 2021 UL http://medrxiv.org/content/early/2021/02/18/2021.02.17.20246504.abstract AB Purpose Obesity-associated fat infiltration of organ systems is accompanied by organ dysfunction and poor cancer outcomes. Obese women demonstrate variable degrees of fat infiltration of axillary lymph nodes (LNs), and they are at increased risk for node-positive breast cancer. However, the relationship between enlarged axillary nodes and axillary metastases has not been investigated. The purpose of this study is to evaluate the association between axillary metastases and fat-enlarged axillary nodes visualized on mammograms and breast MRI in obese women with a diagnosis of invasive breast cancer.Methods This retrospective case-control study included 431 patients with histologically confirmed invasive breast cancer. The primary analysis of this study included 306 patients with pre-operative MRI and body mass index (BMI) > 30 (201 node-positive cases and 105 randomly selected node-negative controls) diagnosed with invasive breast cancer diagnosed between April 1, 2011, and March 1, 2020. The largest visible LN was measured in the axilla contralateral to the known breast cancer on breast MRI. Multivariate logistic regression models were used to assess the association between node-positive status and LN size adjusting for age, BMI, tumor size, tumor grade, tumor subtype, and lymphovascular invasion.Results A strong likelihood of node-positive breast cancer was observed among obese women with fat-expanded lymph nodes (adjusted OR for the 4th vs. 1st quartile for contralateral LN size on MRI: 9.70; 95% CI: 4.26, 23.50; p < 0.001). The receiver operating characteristic curve for size of fat-enlarged nodes in the contralateral axilla identified on breast MRI had an area under the curve of 0.72 for predicting node-positive breast cancer and this increased to 0.80 when combined with patient and tumor characteristics.Conclusion Fat expansion of axillary lymph nodes was associated with a high likelihood of axillary metastases in obese women with invasive breast cancer independent of BMI and tumor characteristics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported in part by grants from the US National Institute of Health (R01CA249758, R01LM012837, P20GM104416).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The use of human subject data in this project is approved by Dartmouth Institutional Review Board (IRB) with a waiver of informed consent from the study participants. This ethical review board is located at 63 South Main Street, HB 6254, Hanover, NH, USA, 03755. Our IRB protocol for this study was approved on 10/03/2018, and its approval file number is STUDY00029037. The conducted research that is reported in this paper complies with the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, S.H., upon reasonable request.